Paper3944273
Probucol inhibits oxidative modification of low density lipoprotein.
Parthasarathy S and 4 others. J Clin Invest, 1986. Cited by 576 papers, by iCite.
Cite this record
ConductScience Library. Probucol inhibits oxidative modification of low density lipoprotein. Papers, record 3944273. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3944273
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelium | Major topic |
| Lipoproteins, LDL | Major topic |
| Phenols | Major topic |
| Probucol | Major topic |
| Animals | |
| Cells, Cultured | |
| Copper | |
| Female | |
| Humans | |
| Hypercholesterolemia | |
| Lipid Peroxides | |
| Macrophages | |
| Mice | |
| Rabbits |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL-14197 | NHLBI NIH HHS | United States | P17HL014197 | PubMed and NIH | NIH RePORTER |
| P50HL014197 | NIH | NIH RePORTER |
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6769124 | Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6769124 | PubMed |
| 2 | 3862109 | Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3862109 | PubMed |
| 4 | 223585 | LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. | Atherosclerosis | 1979 | https://conductscience.org/library/papers/223585 | PubMed |
| 5 | 6520542 | A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. | J Lipid Res | 1984 | https://conductscience.org/library/papers/6520542 | PubMed |
| 6 | 6273873 | Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6273873 | PubMed |
| 7 | 7234961 | The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. | Am J Pathol | 1981 | https://conductscience.org/library/papers/7234961 | PubMed |
| 8 | 5554467 | Influence of 4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol) (DH-581) on experimental atherosclerosis in rabbits. | Proc Soc Exp Biol Med | 1971 | https://conductscience.org/library/papers/5554467 | PubMed |
| 9 | 210450 | Oxygen-mediated heterogeneity of apo-low-density lipoprotein. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/210450 | PubMed |
| 10 | 224077 | Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. | J Clin Invest | 1979 | https://conductscience.org/library/papers/224077 | PubMed |
| 11 | 177050 | Uptake and degradation of low density lipoprotein by swine arterial smoot muscle cells with inhibition of cholesterol biosynthesis. | Biochim Biophys Acta | 1976 | https://conductscience.org/library/papers/177050 | PubMed |
| 12 | 7046693 | Pharmacology and toxicology of probucol. | Artery | 1982 | https://conductscience.org/library/papers/7046693 | PubMed |
| 13 | 230571 | Injury to human endothelial cells in culture induced by low density lipoproteins. | Scand J Clin Lab Invest | 1979 | https://conductscience.org/library/papers/230571 | PubMed |
| 14 | 6415194 | Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. | J Lipid Res | 1983 | https://conductscience.org/library/papers/6415194 | PubMed |
| 15 | 6838433 | Enhanced macrophage degradation of biologically modified low density lipoprotein. | Arteriosclerosis | 1983 | https://conductscience.org/library/papers/6838433 | PubMed |
| 16 | 6491523 | Influence of probucol on cholesterol and lipoprotein metabolism in man. | J Lipid Res | 1984 | https://conductscience.org/library/papers/6491523 | PubMed |
| 17 | 3857630 | Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3857630 | PubMed |
| 18 | 6587396 | Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6587396 | PubMed |
| 19 | 491545 | Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. | Lab Invest | 1979 | https://conductscience.org/library/papers/491545 | PubMed |
| 20 | 6774730 | Malondialdehyde formation in stored plasma. | Biochem Biophys Res Commun | 1980 | https://conductscience.org/library/papers/6774730 | PubMed |
| 21 | 7470200 | Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis. | Atherosclerosis | 1981 | https://conductscience.org/library/papers/7470200 | PubMed |
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 576 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40468139 | A Catalytic Charioteer: An Ode to Sampath Parthasarathy, PhD, MBA, FAHA. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/40468139 | PubMed |
| 38716255 | Probucol mitigates high-fat diet-induced cognitive and social impairments by regulating brain redox and insulin resistance. | Front Neurosci | 2024 | https://conductscience.org/library/papers/38716255 | PubMed |
| 36266995 | Heart failure with preserved ejection fraction and non-alcoholic fatty liver disease: new insights from bioinformatics. | ESC Heart Fail | 2023 | https://conductscience.org/library/papers/36266995 | PubMed |
| 35557540 | High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35557540 | PubMed |
| 35190446 | Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study). | BMJ Open | 2022 | https://conductscience.org/library/papers/35190446 | PubMed |
| 33867420 | Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT. | J Atheroscler Thromb | 2022 | https://conductscience.org/library/papers/33867420 | PubMed |
| 33634671 | Effect of Probucol on Proliferation of Leukemia, Multiple Myeloma, Lymphoma, and Fibroblast Cells. | Turk J Pharm Sci | 2021 | https://conductscience.org/library/papers/33634671 | PubMed |
| 33229816 | New Evidence of Probucol on Cardiovascular Events. | J Atheroscler Thromb | 2021 | https://conductscience.org/library/papers/33229816 | PubMed |
| 32411336 | Evolution of the Knowledge of Free Radicals and Other Oxidants. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32411336 | PubMed |
| 32336695 | Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE). | J Atheroscler Thromb | 2021 | https://conductscience.org/library/papers/32336695 | PubMed |
| 30186318 | Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease. | Neural Plast | 2018 | https://conductscience.org/library/papers/30186318 | PubMed |
| 29581738 | Effect of probucol on hemodynamics, rheology and blood lipid of diabetic retinopathy. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29581738 | PubMed |
| 29518380 | Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed. | Chem Phys Lipids | 2018 | https://conductscience.org/library/papers/29518380 | PubMed |
| 28913547 | Probucol prevents the attenuation of β2-adrenoceptor-mediated vasodilation of retinal arterioles in diabetic rats. | Naunyn Schmiedebergs Arch Pharmacol | 2017 | https://conductscience.org/library/papers/28913547 | PubMed |
| 26945158 | Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents. | J Cardiovasc Pharmacol | 2016 | https://conductscience.org/library/papers/26945158 | PubMed |
| 26366051 | Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. | Diabetes Rev (Alex) | 1997 | https://conductscience.org/library/papers/26366051 | PubMed |
| 25246766 | Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol. | Drug Des Devel Ther | 2014 | https://conductscience.org/library/papers/25246766 | PubMed |
| 24810608 | Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin. | PLoS One | 2014 | https://conductscience.org/library/papers/24810608 | PubMed |
| 24380089 | Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment. | Rev Diabet Stud | 2013 | https://conductscience.org/library/papers/24380089 | PubMed |
| 24095954 | Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis. | Transl Res | 2014 | https://conductscience.org/library/papers/24095954 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SCARF1 | 8578 | PubTator's text mining | https://conductscience.org/library/genes/8578 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3944273
GET https://conductscience.org/api/papers/v1/3944273/references?page=2